The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis

Authors:
  • RMRick van Minkelen
    Rick van Minkelen
  • MVMarieke C. H. de Visser
    Marieke C. H. de Visser
  • HVHans L. Vos
    Hans L. Vos
  • RBRogier M. Bertina
    Rogier M. Bertina
  • FRFrits R. Rosendaal
    Frits R. Rosendaal

Abstract
FSAP is a serine protease that has 2 functions in hemostasis. It activates factor VII, thereby promoting coagulation,3 but it can also activate single-chain plasminogen activators, thus promoting fibrinolysis.4 Recently, a single nucleotide polymorphism (1601G>A) was discovered in the gene coding for FSAP, which results in the substitution of glycine 511 by glutamic acid (FSAP Marburg I) and which is present in 2% to 9% of the white population.1,5,6 The Marburg I variant has an impaired prourokinase activating potency, whereas it can still activate factor VII normally.7

This publication has 10 references indexed in Scilit: